China Healthcare Sector Report 2021 4th Quarter

In Q3 2021, Chinese residents’ expenditures on medicine and medical services continued to increase. Per capita spending of urban residents reached RMB 635, up by 10.8% y/y, and that of rural residents recorded a growth of 9.8% y/y to RMB 422. During the quarter, the significant regional disparities in healthcare provision remained, with rural areas relatively underserved. Under the 14th Five-Year Plan (2021-2025), the government plans to focus on cultivating more medical personnel, expanding rural medical infrastructure and enhancing the country’s hierarchical social medical system, to improve inclusion and equality of healthcare services across regions.

This report provides a complete and detailed analysis of the healthcare sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the healthcare sector in China
• Access forecasts for growth in the sector
• View key data on healthcare spending and health insurance in China
• Crystallise the forces both driving and restraining this sector in China
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in China
• Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).

See below for a complete table of report contents: